Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR+/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p

Liushan Chen(Guangzhou University of Chinese Medicine), Qianjun Chen(Guangzhou University of Chinese Medicine)
Scientific Reports
December 28, 2024
Cited by 2


Related Papers